Compare Medpace Holdings Inc (MEDP) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Western Union Co — how do they compare? Medpace Holdings Inc trades at $602.96 (market cap $16.90B), while Western Union Co trades at $6.99 (market cap $2.20B). The key difference: Medpace Holdings Inc is far larger — about 7.7× Western Union Co's market cap, and Western Union Co pays a 13.33% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | WU | |
|---|---|---|
Market Cap | $16.90B | $2.20B |
Sector | Technology | Technology |
52-Week High | $620.59 | $10.28 |
52-Week Low | $393.42 | $6.36 |
Enterprise Value | $16.52B | $2.10B |
Dividend Yield | — | 13.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
Western Union (WU) trades at $6.985, down 0.64% on the day, with a bearish technical signal and recent earnings misses in Q1 and Q2 2026. The company maintains a dividend of $0.24 per share and shows strong profitability with a 9.79% net income margin and 43.97% ROE, but revenue has declined from $4.5B in 2022 to $4.05B in 2025. Analyst consensus is mixed with a $7.14 price target, but news highlights challenges like retail money transfer weakness and strategic shifts.
The outlook is cautious due to declining revenue, earnings volatility, and bearish sentiment, though low valuation ratios (P/E of 5.69) may appeal to value investors. Risks include competitive pressures and execution hurdles in digital transitions, requiring close monitoring of upcoming Q3 earnings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
